Vericel Balance Sheet
NASDAQ: VCELHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Vericel financial position
At the end of fiscal 2025, Vericel reported total assets of $488.0 million, up 12.8% from a year earlier against total liabilities of $133.3 million. Shareholders' equity stood at $354.6 million, or 72.7% of assets. The company held $100.1 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 5.03, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Vericel balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 100.09M | 74.52M | 69.09M | 51.07M | 68.33M | 33.62M | 26.89M | 18.29M | 26.86M | 22.98M |
| Short-Term Investments | 37.41M | 41.69M | 40.47M | 68.47M | 35.07M | 42.19M | 42.83M | 64.64M | 0 | — |
| Receivables | 84.63M | 61.38M | 58.36M | 46.54M | 37.44M | 34.50M | 32.17M | 23.45M | 18.27M | 17.09M |
| Inventory | 17.56M | 17.37M | 13.09M | 15.99M | 13.38M | 9.36M | 6.82M | 3.56M | 3.79M | 3.49M |
| Total Current Assets | 247.44M | 212.78M | 205.63M | 186.87M | 158.46M | 123.56M | 111.66M | 112.78M | 50.51M | 44.72M |
| Property, Plant & Equipment | 108.40M | 103.16M | 41.63M | 15.84M | 13.31M | 7.63M | 7.14M | 5.91M | 4.07M | 3.88M |
| Intangible Assets | 5.63M | 6.25M | 6.88M | 7.50M | 0 | — | — | — | — | 0 |
| Long-Term Investments | 61.40M | 39.88M | 25.28M | 19.96M | 25.69M | 24.10M | 9.25M | 0 | — | — |
| Total Assets | 487.97M | 432.72M | 353.66M | 273.00M | 243.71M | 205.61M | 153.24M | 118.69M | 54.58M | 48.60M |
| Accounts Payable | 15.83M | 23.85M | 22.35M | 16.93M | 9.02M | 6.75M | 6.34M | 7.11M | 5.55M | 6.54M |
| Total Current Liabilities | 49.15M | 50.29M | 45.75M | 37.46M | 26.05M | 22.48M | 19.80M | 14.79M | 13.09M | 12.85M |
| Long-Term Debt | — | — | — | — | — | — | — | — | 16.89M | 9.32M |
| Total Liabilities | 133.33M | 140.75M | 127.70M | 80.73M | 73.24M | 71.35M | 42.15M | 16.46M | 32.04M | 23.89M |
| Shareholders' Equity | 354.64M | 291.97M | 225.95M | 192.27M | 170.46M | 134.26M | 111.09M | 102.23M | 22.54M | 24.71M |
| Retained Earnings | -376.30M | -392.81M | -403.18M | -400.00M | -383.29M | -375.81M | -378.68M | -369.01M | -360.88M | -343.59M |
| Total Debt | — | — | — | — | — | — | — | — | 16.89M | 9.32M |
| Net Cash (Debt) | 137.50M | 116.21M | 109.56M | 119.54M | 103.40M | 75.81M | 69.72M | 82.92M | 9.97M | 13.66M |
| Shares Outstanding | 50.62M | 49.63M | 47.83M | 47.25M | 46.88M | 45.80M | 44.86M | 43.58M | 35.86M | 31.59M |
This table shows 10 annual periods of Vericel's balance sheet, from FY 2025 back to FY 2016, across 19 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow VCEL's reporting calendar. What is a balance sheet?